Skip to main content
. 2020 Oct 29;22:258. doi: 10.1186/s13075-020-02326-5

Table 2.

Rates and reasons for discontinuation

Etanercept cohort (N = 2725)
Discontinuations 1655 (60.7)
Remission 652 (23.9)
Inefficacy 594 (21.8)
Intolerance 192 (7.1)
Patient’s demand 504 (18.5)
Others 287 (10.5)

Data are shown as n (%). Multiple reasons could be given